pamidronate has been researched along with Osteoporotic Fractures in 7 studies
Osteoporotic Fractures: Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some children with cerebral palsy (CP) have frequent fractures due to low bone mineral density and receive treatment with pamidronate, an intravenous bisphosphonate." | 7.83 | Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy. ( Bachrach, S; Dabney, K; Holmes, L; Kecskemethy, HH; Miller, F; Rogers, KJ; Sees, JP; Sitoula, P, 2016) |
| " Here, a case of a 9-year-old girl with familial HCS and multiple spinal fractures, who has been effectively treated with pamidronate, is presented." | 7.78 | Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. ( Galli-Tsinopoulou, A; Giannopoulou, EZ; Giza, S; Kyrgios, I; Laliotis, N; Maggana, I, 2012) |
| "Some children with cerebral palsy (CP) have frequent fractures due to low bone mineral density and receive treatment with pamidronate, an intravenous bisphosphonate." | 3.83 | Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy. ( Bachrach, S; Dabney, K; Holmes, L; Kecskemethy, HH; Miller, F; Rogers, KJ; Sees, JP; Sitoula, P, 2016) |
| " Here, a case of a 9-year-old girl with familial HCS and multiple spinal fractures, who has been effectively treated with pamidronate, is presented." | 3.78 | Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. ( Galli-Tsinopoulou, A; Giannopoulou, EZ; Giza, S; Kyrgios, I; Laliotis, N; Maggana, I, 2012) |
| "Osteogenesis imperfecta is characterised by bone fragility leading to fracture and bone deformity, chronic bone pain and reduced mobility." | 1.36 | Characterising and treating osteogenesis imperfecta. ( Bishop, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lotan, M | 1 |
| Reves-Siesel, R | 1 |
| Eliav-Shalev, RS | 1 |
| Merrick, J | 1 |
| Sees, JP | 1 |
| Sitoula, P | 1 |
| Dabney, K | 1 |
| Holmes, L | 1 |
| Rogers, KJ | 1 |
| Kecskemethy, HH | 1 |
| Bachrach, S | 1 |
| Miller, F | 1 |
| Singh, A | 1 |
| Schaeffer, EK | 1 |
| Reilly, CW | 1 |
| Torregrosa, JV | 1 |
| Fuster, D | 1 |
| Monegal, A | 1 |
| Gentil, MA | 1 |
| Bravo, J | 1 |
| Guirado, L | 1 |
| Muxí, A | 1 |
| Cubero, J | 1 |
| Bishop, N | 1 |
| Laroche, M | 1 |
| Livideanu, C | 1 |
| Paul, C | 1 |
| Cantagrel, A | 1 |
| Galli-Tsinopoulou, A | 1 |
| Kyrgios, I | 1 |
| Giza, S | 1 |
| Giannopoulou, EZ | 1 |
| Maggana, I | 1 |
| Laliotis, N | 1 |
1 trial available for pamidronate and Osteoporotic Fractures
| Article | Year |
|---|---|
Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeli | 2011 |
6 other studies available for pamidronate and Osteoporotic Fractures
| Article | Year |
|---|---|
Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Infant; Osteoporosis | 2013 |
Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy.
Topics: Adolescent; Bone Density Conservation Agents; Cerebral Palsy; Child; Child, Preschool; Diphosphonate | 2016 |
Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Child; Diphosph | 2018 |
Characterising and treating osteogenesis imperfecta.
Topics: Bone and Bones; Bone Density Conservation Agents; Collagen Type I; Diagnosis, Differential; Diphosph | 2010 |
Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combinati | 2011 |
Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome.
Topics: Abnormalities, Multiple; Acro-Osteolysis; Bone Density; Bone Density Conservation Agents; Child; Dip | 2012 |